The U.S. Food and Drug Administration (FDA) has cleared a conebeam CT module from radiation oncology software firm Mobius Medical Systems.
Designed to work with the company's Mobius3D software, the module is an online tool for evaluating patient positioning and patient anatomy changes. It can reveal incorrect positioning, changes in patient anatomy such as weight loss, and even incorrect bolus placement, according to the firm.
